Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marconi

Showing results (381-390 of 393) with videos related to

Pageof 40
Sort By:
MMWR. Morbidity and Mortality Weekly Report|December 9, 2021
Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021Kristina L Bajema, Rebecca M Dahl, Steve L Evener, et al.
Plos Medicine|January 12, 2024
The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling studyKeri N Althoff, Cameron Stewart, Elizabeth Humes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2015
The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United StatesColleen S Kraft, Angela L Hewlett, Scott Koepsell, et al.
The Lancet. Infectious Diseases|February 13, 2025
Targeting the SARS-CoV-2 reservoir in long COVIDAmy D Proal, Soo Aleman, Morgane Bomsel, et al.
Ebiomedicine|April 3, 2017
Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International CollaborationSoo-Yon Rhee, Vici Varghese, Susan P Holmes, et al.
Open Forum Infectious Diseases|January 5, 2023
The US Department of Veterans Affairs Science and Health Initiative to Combat Infectious and Emerging Life-Threatening Diseases (VA SHIELD): A Biorepository Addressing National Health ThreatsJohn B Harley, Saiju Pyarajan, Elizabeth S Partan, et al.
Annals of Internal Medicine|November 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment TrialGail E Potter, Tyler Bonnett, Kevin Rubenstein, et al.
The Journal of Infectious Diseases|May 21, 2013
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudineMichele W Tang, Soo-Yon Rhee, Silvia Bertagnolio, et al.
JAMA|December 18, 2024
2024 Update of the RECOVER-Adult Long COVID Research IndexLinda N Geng, Kristine M Erlandson, Mady Hornig, et al.
The New England Journal of Medicine|December 11, 2020
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19Andre C Kalil, Thomas F Patterson, Aneesh K Mehta, et al.
Pageof 40

Showing results (381-390 of 393) with videos related to

Sort By:
Pageof 40
MMWR. Morbidity and Mortality Weekly Report|December 9, 2021
Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021Kristina L Bajema, Rebecca M Dahl, Steve L Evener, et al.
Plos Medicine|January 12, 2024
The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling studyKeri N Althoff, Cameron Stewart, Elizabeth Humes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2015
The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United StatesColleen S Kraft, Angela L Hewlett, Scott Koepsell, et al.
The Lancet. Infectious Diseases|February 13, 2025
Targeting the SARS-CoV-2 reservoir in long COVIDAmy D Proal, Soo Aleman, Morgane Bomsel, et al.
Ebiomedicine|April 3, 2017
Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International CollaborationSoo-Yon Rhee, Vici Varghese, Susan P Holmes, et al.
Open Forum Infectious Diseases|January 5, 2023
The US Department of Veterans Affairs Science and Health Initiative to Combat Infectious and Emerging Life-Threatening Diseases (VA SHIELD): A Biorepository Addressing National Health ThreatsJohn B Harley, Saiju Pyarajan, Elizabeth S Partan, et al.
Annals of Internal Medicine|November 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment TrialGail E Potter, Tyler Bonnett, Kevin Rubenstein, et al.
The Journal of Infectious Diseases|May 21, 2013
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudineMichele W Tang, Soo-Yon Rhee, Silvia Bertagnolio, et al.
JAMA|December 18, 2024
2024 Update of the RECOVER-Adult Long COVID Research IndexLinda N Geng, Kristine M Erlandson, Mady Hornig, et al.
The New England Journal of Medicine|December 11, 2020
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19Andre C Kalil, Thomas F Patterson, Aneesh K Mehta, et al.
Pageof 40